Morgan Stanley’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9M Buy
9,072,400
+90,738
+1% +$214K ﹤0.01% 2788
2025
Q4
$17.2M Buy
8,981,662
+4,009,630
+81% +$9.5M ﹤0.01% 3074
2025
Q3
$11M Buy
4,972,032
+217,844
+5% +$523K ﹤0.01% 3460
2025
Q2
$6.8M Buy
4,754,188
+708,859
+18% +$1.03M ﹤0.01% 3800
2025
Q1
$6.47M Buy
4,045,329
+205,860
+5% +$614K ﹤0.01% 3706
2024
Q4
$13.8M Buy
3,839,469
+1,513,335
+65% +$7.52M ﹤0.01% 3097
2024
Q3
$13.3M Buy
2,326,134
+1,188,196
+104% +$7.15M ﹤0.01% 3203
2024
Q2
$5.26M Buy
1,137,938
+623,755
+121% +$3.72M ﹤0.01% 3831
2024
Q1
$4.2M Buy
514,183
+103,501
+25% +$802K ﹤0.01% 4043
2023
Q4
$2.32M Buy
410,682
+97,605
+31% +$223K ﹤0.01% 4839
2023
Q3
$582K Buy
313,077
+72,038
+30% +$220K ﹤0.01% 5102
2023
Q2
$663K Sell
241,039
-53,099
-18% -$171K ﹤0.01% 5072
2023
Q1
$924K Sell
294,138
-85,061
-22% -$501K ﹤0.01% 4907
2022
Q4
$2.24M Buy
379,199
+34,812
+10% +$289K ﹤0.01% 4380
2022
Q3
$3.02M Sell
344,387
-111,069
-24% -$1.15M ﹤0.01% 4109
2022
Q2
$3.43M Sell
455,456
-202,116
-31% -$1.78M ﹤0.01% 4098
2022
Q1
$16M Sell
657,572
-260,898
-28% -$6.34M ﹤0.01% 2366
2021
Q4
$29.6M Buy
918,470
+628,374
+217% +$24.8M ﹤0.01% 1754
2021
Q3
$13M Buy
290,096
+13,908
+5% +$596K ﹤0.01% 2587
2021
Q2
$10.5M Buy
276,188
+254,993
+1,203% +$9.13M ﹤0.01% 2923
2021
Q1
$784K Buy
21,195
+12,087
+133% +$481K ﹤0.01% 4879
2020
Q4
$302K Buy
+9,108
New +$264K ﹤0.01% 5368

Other funds holding CCCC